Spine Surgery EducationPublication rates of abstracts presented across 6 major spine specialty conferences
Keywords
Cited by (0)
FDA device/drug status: Not applicable.
Author disclosures: TZI: Nothing to disclose. YL: Nothing to disclose. MJL: Nothing to disclose. CR: Nothing to disclose. RC: Nothing to disclose. JK: Nothing to disclose. JAC: Nothing to disclose. ARV: Royalties: Stryker (F), Globus (D), Medtronic (F), Atlas (B), Alphatech Spine (B), Elsevier (A), Jaypee (A), Taylor Francis/Hodder and Stoughton (A), Thieme (B); Stock Ownership: Accelus (100,000 shares), Advanced Spinal Intellectual Properties (29% ownership), Atlas (25,000 shares), Avaz Surgical (277 shares), AVKN Patient Driven Care (50% ownership), Cytonics (25,000 shares), Deep Health (830 shares), Dimension Orthotics LLC (20.62% ownership), Electrocore (38,439 shares), Flagship Surgical (50,000 shares), FlowPharma (200,000 shares), Globus (123,398 shares), Harvard MedTech (20,000 shares), Innovative Surgical Design (35,484 shares), Jushi (Haywood) (135,980 shares), Nuvasive (30,000 shares), Orthobullets (30,000 shares), Parvizi Surgical Innovation (100,000 shares), Progressive Spinal Technologies (14.5% ownership), Replication Medica (15,000 shares), Sentryx (40,000 shares), Stout Medical (561 shares), ViewFi Health (5,000 shares); Consulting: Globus (B). CKK: Nothing to disclose. GDS: Nothing to disclose. ASH: Royalties: Zimmer Biomet (F), CTL Medical Corporation (C).